Newly Diagnosed
Get started learning about lymphoma

Donate
You can make a real difference

Register or  Log-In
Get e-mail updates on what's important to you


Charity Navigator
Best in America

Printer Friendly Page

Talk to a Trained Helpline Staff Member
Information on your diagnosis
1.800.500.9976
helpline@lymphoma.org
Monday-Friday 8am-4pm PST

Scientific Advisory Board Bookmark and Share

The Lymphoma Research Foundation remains dedicated to finding a cure for lymphoma through an aggressively-funded research program. The Foundation's Scientific Advisory Board (SAB), comprised of 45 world-renowned lymphoma experts, guides the Foundation's research activities, seeking out the most innovative and promising lymphoma research projects for support.

In addition to reviewing and approving grant applications for lymphoma research, the SAB meets annually to discuss the Foundation's scientific agenda and explore ways to expand its research efforts in order to accelerate the development successful treatments and ultimately a cure.

Scientific Advisory Board Members 
July 1, 2010 to June 30, 2011

Bruce D. Cheson, MD, FACP, Chair
Georgetown University Hospital


John P. Leonard, MD, Chair Elect

Weill Medical College of Cornell University

 

Ranjana Advani, MD

Stanford University School of Medicine

 

Stephen Ansell, MD, PhD

Mayo Medical School

 

Nancy Bartlett, MD

Washington University School of Medicine

 

John C. Byrd, MD

The Ohio State University

 

Michael A. Caligiuri, MD

The Ohio State University

 

George P. Canellos, MD

Dana-Farber Cancer Institute

  

John Chan, MD

University of Nebraska Medical Center

 

Morton Coleman, MD

Weill Medical College of Cornell University

 

Joseph M. Connors, MD, FRCPC

BC Cancer Agency

 

Carlo Croce, MD

The Ohio State University

 

Myron Czuczman, MD

Roswell Park Cancer Institute

 

Riccardo Dalla-Favera, MD

Columbia University

 

Martin Dreyling, MD, PhD

University of Munich-Grosshadern

 

Kojo S.J. Elenitoba-Johnson, MD

University of Michigan Medical School


Richard I. Fisher, MD
University of Rochester

 

Arnold S. Freedman, MD

Dana-Farber Cancer Institute

 

Jonathan Friedberg, MD

University of Rochester

 

Randy Gascoyne, MD

BC Cancer Agency

 

Leo I. Gordon, MD

Northwestern University Medical School

  

Thomas M. Habermann, MD

Mayo College of Medicine


Elaine S. Jaffe, MD

National Cancer Institute

Brad S. Kahl, MD

University of Wisconsin Medical School

 

Neil Kay, MD

Mayo Clinic

 

Thomas J. Kipps, MD, PhD
University of California, San Diego

 

Larry W. Kwak, MD, PhD

The University of Texas

 

Ronald Levy, MD

Stanford University School of Medicine

Izadore Lossos, MD
University of Miami

 

David G. Maloney, MD, PhD

University of Washington

 

Ari Melnick, MD

Weill Cornell Medical College

 

Thomas P. Miller, MD

University of Arizona

 

Craig Moskowitz, MD

Memorial Sloan-Kettering Cancer Center

 

Susan O'Brien, MD

The University of Texas


Owen O’Connor, MD, PhD
New York University

 

Carol Portlock, MD

Memorial Sloan-Kettering Cancer Center

 

Oliver Press, MD, PhD

University of Washington Medical Center

 

Kanti R. Rai, MD, BS
Long Island Jewish Medical Center

 

Lisa Rimsza, MD

University of Arizona
 

Louis M. Staudt, MD, PhD
Metabolism Branch, NCI

 

Julie M. Vose, MD

University of Nebraska Medical Center

 

Michael E. Williams, MD

University of Virginia School of Medicine


Wyndham Wilson, MD, PhD
National Cancer Institute

Thomas Witzig, MD
Mayo Clinic College of Medicine

Anas Younes, MD
University of Texas
 

Andrew D. Zelenetz, MD, PhD

Memorial Sloan-Kettering Cancer Center


 

 LRF Scientific Advisory Board